Comparisons of pharmacokinetics and NO-releasing of nitrofibriate and fenofibrate after oral administration in rats.

about

Comparisons of pharmacokinetics and NO-releasing of nitrofibriate and fenofibrate after oral administration in rats.

Item

http://www.wikidata.org/entity/Q36043356

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparisons of pharmacokinetic ...... r oral administration in rats.

@ast

Comparisons of pharmacokinetic ...... r oral administration in rats.

@en

type

Item

label

Comparisons of pharmacokinetic ...... r oral administration in rats.

@ast

Comparisons of pharmacokinetic ...... r oral administration in rats.

@en

prefLabel

Comparisons of pharmacokinetic ...... r oral administration in rats.

@ast

Comparisons of pharmacokinetic ...... r oral administration in rats.

@en

P1476

Comparisons of pharmacokinetic ...... r oral administration in rats.

@en

P2093

Qiang Cheng

http://www.w3.org/2001/XMLSchema#string

Tingting Li

http://www.w3.org/2001/XMLSchema#string

Xiumei Liu

http://www.w3.org/2001/XMLSchema#string

Xuehua Jiang

http://www.w3.org/2001/XMLSchema#string

Yujie Yang

http://www.w3.org/2001/XMLSchema#string

Zejuan Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Insights into cGMP signalling derived from cGMP kinase knockout mice.

The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patient.

New metabolites of fenofibrate in Sprague-Dawley rats by UPLC-ESI-QTOF-MS-based metabolomics coupled with LC-MS/MS

Halting arterial aging in patients with cardiovascular disease: hypolipidemic and antihypertensive therapy.

Enhancing the pharmacodynamic profile of a class of selective COX-2 inhibiting nitric oxide donors.

Pleiotropic effects of fenofibrate therapy on rats with hypertriglycemia.

In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor

Peroxisome proliferator-activated receptor alpha agonists increase nitric oxide synthase expression in vascular endothelial cells.

Preparation of fenofibrate nanosuspension and study of its pharmacokinetic behavior in rats.

Species differences in the chirality of the carbonyl reduction of [14C] fenofibrate in laboratory animals and humans.

P304

2003-2008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BMC.3777

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ling Wang

P577

2016-06-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27270950

http://www.w3.org/2001/XMLSchema#string